Maria Efthymiou

Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

Hannah Cohen, Beverley J. Hunt, Maria Efthymiou et al. · The Lancet Haematology · 2016 · 404 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Mutations in BMP4 Cause Eye, Brain, and Digit Developmental Anomalies: Overlap between the BMP4 and Hedgehog Signaling Pathways

Preeti Bakrania, Maria Efthymiou, Johannes Klein et al. · The American Journal of Human Genetics · 2008 · 249 citations · Full text

Life Sciences, Developmental Biology, Genetics +16

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort

Massimo Radin, Savino Sciascia, Doruk Erkan et al. · Seminars in Arthritis and Rheumatism · 2019 · 114 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +14

Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction

Kristian Bailey, Simon P.R. Romaine, Beryl M. Jackson et al. · Circulation Cardiovascular Genetics · 2010 · 106 citations

Medicine, Genetics, Pharmacology +17

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

Deepa J. Arachchillage, Maria Efthymiou, Ian Mackie et al. · Journal of Thrombosis and Haemostasis · 2014 · 82 citations · Full text

Medicine, Hematology, Immunology +15